Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses ...
Verywell Health on MSN
What happens to your cold when you take zinc
Medically reviewed by Violetta Shamilova, PharmD Key Takeaways Zinc won’t prevent a cold, but it may help you recover faster ...
AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Learn how a newly discovered virus disrupts its host’s nucleus in ways that echo how complex cells may have formed billions ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Scientists have uncovered a surprising viral shortcut that turns moving cells into delivery vehicles for infection. Instead ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Ushikuvirus is a newly identified giant virus that infects amoebas, adding to a growing group of oversized viruses that scientists believe may have played an important role in the emergence of complex ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Baculoviruses are a diverse group of insect viruses that have long served as both biological control agents in agriculture and versatile tools in biotechnology. Their life cycle is marked by two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback